PROCTER & GAMBLE HEALTH | LAURUS LABS | PROCTER & GAMBLE HEALTH/ LAURUS LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 140.1 | 24.7% | View Chart |
P/BV | x | 10.6 | 5.9 | 180.3% | View Chart |
Dividend Yield | % | 2.0 | 0.5 | 439.5% |
PROCTER & GAMBLE HEALTH LAURUS LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
LAURUS LABS Mar-23 |
PROCTER & GAMBLE HEALTH/ LAURUS LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 626 | 857.1% | |
Low | Rs | 3,883 | 287 | 1,353.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 112.1 | 660.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 14.8 | 934.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 20.8 | 745.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 0.4 | 468.8% | |
Book value per share (Unadj.) | Rs | 447.6 | 74.7 | 599.0% | |
Shares outstanding (eoy) | m | 16.60 | 538.65 | 3.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 4.1 | 153.4% | |
Avg P/E ratio | x | 33.5 | 30.9 | 108.4% | |
P/CF ratio (eoy) | x | 29.8 | 21.9 | 135.9% | |
Price / Book Value ratio | x | 10.3 | 6.1 | 169.2% | |
Dividend payout | % | 68.7 | 13.5 | 508.2% | |
Avg Mkt Cap | Rs m | 76,761 | 245,840 | 31.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 5,574 | 37.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 60,406 | 20.4% | |
Other income | Rs m | 184 | 60 | 306.5% | |
Total revenues | Rs m | 12,480 | 60,466 | 20.6% | |
Gross profit | Rs m | 3,247 | 15,922 | 20.4% | |
Depreciation | Rs m | 281 | 3,241 | 8.7% | |
Interest | Rs m | 8 | 1,652 | 0.5% | |
Profit before tax | Rs m | 3,142 | 11,089 | 28.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 3,123 | 27.1% | |
Profit after tax | Rs m | 2,295 | 7,966 | 28.8% | |
Gross profit margin | % | 26.4 | 26.4 | 100.2% | |
Effective tax rate | % | 27.0 | 28.2 | 95.8% | |
Net profit margin | % | 18.7 | 13.2 | 141.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 34,617 | 33.8% | |
Current liabilities | Rs m | 6,791 | 24,323 | 27.9% | |
Net working cap to sales | % | 40.0 | 17.0 | 234.9% | |
Current ratio | x | 1.7 | 1.4 | 121.2% | |
Inventory Days | Days | 263 | 14 | 1,817.1% | |
Debtors Days | Days | 343 | 10 | 3,596.7% | |
Net fixed assets | Rs m | 10,617 | 41,987 | 25.3% | |
Share capital | Rs m | 166 | 1,077 | 15.4% | |
"Free" reserves | Rs m | 7,265 | 39,177 | 18.5% | |
Net worth | Rs m | 7,431 | 40,255 | 18.5% | |
Long term debt | Rs m | 0 | 7,614 | 0.0% | |
Total assets | Rs m | 22,330 | 76,604 | 29.1% | |
Interest coverage | x | 409.1 | 7.7 | 5,302.8% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 69.8% | |
Return on assets | % | 10.3 | 12.6 | 82.1% | |
Return on equity | % | 30.9 | 19.8 | 156.0% | |
Return on capital | % | 42.4 | 26.6 | 159.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 22.7 | 57.5% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | 13,720 | 11.7% | |
Fx inflow | Rs m | 1,465 | 43,470 | 3.4% | |
Fx outflow | Rs m | 1,605 | 13,720 | 11.7% | |
Net fx | Rs m | -140 | 29,750 | -0.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 9,939 | 23.7% | |
From Investments | Rs m | -215 | -9,961 | 2.2% | |
From Financial Activity | Rs m | -985 | -266 | 369.6% | |
Net Cashflow | Rs m | 1,160 | -297 | -390.9% |
Indian Promoters | % | 0.0 | 27.2 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 37.8 | 52.9% | |
FIIs | % | 6.2 | 26.0 | 24.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 72.8 | 66.2% | |
Shareholders | 56,778 | 356,830 | 15.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | LAURUS LABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 2.77% | 0.45% |
1-Month | -1.15% | 10.00% | 2.55% |
1-Year | 0.73% | 45.68% | 56.14% |
3-Year CAGR | -8.76% | -2.05% | 15.22% |
5-Year CAGR | 4.97% | 41.38% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the LAURUS LABS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of LAURUS LABS the stake stands at 27.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of LAURUS LABS .
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
LAURUS LABS paid Rs 2.0, and its dividend payout ratio stood at 13.5%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of LAURUS LABS .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.